Search


EMA EMA 2025 AI Observatory Report: Artificial Intelligence in Medicines Regulation
Artificial Intelligence (AI) is rapidly becoming an integral part of pharmaceutical development and regulatory operations. From drug discovery and clinical trials to manufacturing and pharmacovigilance, AI is transforming how medicines are developed, assessed, and monitored. The European Medicines Agency (EMA) published its 2025 AI Observatory Report to provide an overview of AI-related activities across the European Medicines Regulatory Network (EMRN). The report highlights

Sharan Murugan
1 day ago3 min read
